Medical Mycology, March 2010, 48, 318–327
The clinical spectrum of Exophiala jeanselmei,
with a case report and in vitro antifungal susceptibility
of the species
Exophiala jeanselmei is clinically redefined as a rare agent of subcutaneous lesions of
traumatic origin, eventually causing eumycetoma. Mycetoma is a localized, chronic,
suppurative subcutaneous infection of tissue and contiguous bone after a traumatic inoculation of the causative organism. In advanced stages of the infection, one finds tumefaction, abscess formation and draining sinuses. The species has been described as being
common in the environment, but molecular methods have only confirmed its occurrence
in clinical samples. Current diagnostics of E. jeanselmei is based on sequence data of
the Internal Transcribed Spacer (ITS) region of ribosomal DNA (rDNA), which sufficiently reflects the taxonomy of this group. The first purpose of this study was the
re-identification of all clinical (n ⫽ 11) and environmental strains (n ⫽ 6) maintained
under the name E. jeanselmei, and to establish clinical preference of the species in its
restricted sense. Given the high incidence of eumycetoma in endemic areas, the second
goal of this investigation was the evaluation of in vitro susceptibility of E. jeanselmei
to eight conventional and new generations of antifungal drugs to improve antifungal
therapy in patients. As an example, we describe a case of black grain mycetoma in a
43-year-old Thai male with several draining sinuses involving the left foot. The disease required extensive surgical excision coupled with intense antifungal chemotherapy
to achieve cure. In vitro studies demonstrated that posaconazole and itraconazole had
the highest antifungal activity against E. jeanselmei and E. oligosperma for which high
MICs were found for caspofungin. However, their clinical effectiveness in the treatment
of Exophiala infections remains to be determined.
Keywords Exophiala jeanselmei, black yeasts, ITS rDNA, mycetoma, antifungal
susceptibility testing
Introduction
Mycetoma is defined as a localized, chronic, granulomatous, suppurative and progressive inflammatory disease of
subcutaneous tissue and contiguous bone after a traumatic
inoculation of the causative organism [1]. Etiologic agents
Received 9 March 2009; Received in final revised form 6 May 2009;
Accepted 28 June 2009
Correspondence: G.S. de Hoog, Uppsalalaan 8, 3584 CT, Utrecht, The
Netherlands. Tel: +31 30 2122 663; E-mail: de.hoog@cbs.knaw.nl
2010 ISHAM
are recovered from humans as well as domestic animals
[2]. In advanced stages of the infection tumefaction, abscess
formation and draining sinuses arise. The hallmark of a
mycetoma is the presence of the fungus in the form of
grains. In Africa the infection is particularly common from
Sudan to Senegal, an area known as the ‘mycetoma belt’.
The main etiologic agents in that area are Madurella mycetomatis and Leptosphaeria senegalensis. Other recurrent
fungal agents are Madurella grisea and several species of
coelomycetes.
DOI: 10.3109/13693780903148353
Downloaded from https://academic.oup.com/mmy/article/48/2/318/1014535 by guest on 02 September 2021
H. BADALI*†‡, M. J. NAJAFZADEH*†, M. VAN ESBROECK§, E. VAN DEN ENDEN§, B. TARAZOOIE*,
J. F. G. M. MEIS^ & G. S. DE HOOG*†
*CBS-KNAW Fungal Biodiversity Centre, Utrecht, The Netherlands, †Institute of Biodiversity and Ecosystem Dynamics, University
of Amsterdam, Amsterdam,The Netherlands, ‡Department of Medical Mycology and Parasitology, School of Medicine, Mazandaran
University of Medical Sciences, Sari, Iran, §Institute of Tropical Medicine, Antwerp, Belgium, and ^Department of Medical
Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen,The Netherlands
The clinical spectrum of Exophiala jeanselmei
to the species level cannot be performed by molecular
methods. It is possible that the etiological agent may often
have been misdiagnosed. In this article, a case of eumycetoma caused by E. jeanselmei matching the original clinical concept of the species is presented.
Current diagnostics of E. jeanselmei is achieved through
the use of sequence data of the Internal Transcribed Spacer
(ITS) region of ribosomal DNA (rDNA), which reflects the
taxonomy of this group [14]. Therefore, the first purpose
of this study was the re-identification of all clinical
(n ⫽ 11) and environmental strains (n ⫽ 6) preserved
under the name E. jeanselmei in the collection of Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands,
and to establish the species clinical manifestations. Given
the high incidence of eumycetoma in endemic areas, the
second goal of this study was the evaluation of the in vitro
susceptibility of E. jeanselmei to eight conventional and
new generations of antifungal drugs to improve the antifungal therapy in patients. New antifungal agents with a
better activity may help to improve the management of
eumycetoma as sufficient knowledge is gained as to the
in vitro activity of new antifungal agents.
Materials and methods
Fungal strains
Strains used in this study were obtained from the Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands
(Table 1), deposited and phenotypically identified
E. jeanselmei. Stock cultures were maintained on slants of
Table 1 Summary of source and identification of strains tested.
CBS number
Other collection
CBS 122239
CBS 119095
CBS 109635
CBS 148.97
CBS 507.90
CBS 116.86
CBS 677.76
CBS 664.76
CBS 528.76
CBS 814.95
CBS 634.69
CBS 538.76
CBS 537.76
CBS 642.82
CBS 527.76
dH 18920
dH 13453
dH 12305
dH 10808
dH 15933 (T)
dH 15309
dH 16163
ATCC 34123
ATCC10224
dH 16266
dH 16108
dH 15984
dH 15981
dH 16117
dH 15966
CBS 102241
CBS 663.76
dH 11605
dH 16149
Source
Man, mycetoma
Man, foot skin
Man, arm lesion
Man, subcutaneous cyst
Man, mycetoma
Man, chromomycosis
Man, mycetoma
Man, skin infection
Man, hand skin lesion
Soil biofilter
Wood, ship resting
Man, bronchus
Man, eye infection
Soft rot of preservative-treated wood
Culture contaminant of Hyphodontia
breviseta
Soil under coffee plant
Wood
Country
Reference
Final name
Thailand
USA, Dallas
USA, San Antonio
Japan, Ibaraki
France
Japan
Pakistan
None
None
Netherlands, Delft
Baltic Sea
None
Italy
Australia, Lucia
Sweden, Bohuslan
Current paper
None
[13]
[22]
[20]
[10]
[21]
[23]
None
[13]
None
None
[24]
None
None
Exophiala jeanselmei
Exophiala jeanselmei
Exophiala jeanselmei
Exophiala jeanselmei
Exophiala jeanselmei
Exophiala jeanselmei
Exophiala jeanselmei
Exophiala jeanselmei
Exophiala jeanselmei
Exophiala oligosperma
Exophiala oligosperma
Exophiala oligosperma
Exophiala oligosperma
Exophiala oligosperma
Exophiala xenobiotica
Brazil, Paraná
None
None
[23]
Exophiala bergeri
Capronia pilosella
Abbrevations used: ATCC ⫽ American Type Culture Collection, Manassas, U.S.A.; CBS ⫽ Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands;
DH ⫽ G.S. de Hoog working collection; IFM ⫽ Research Institute for Pathogenic Fungi, Chiba, Japan; IHM ⫽ Laboratory of Mycology, Faculty of
Medicine, Montevideo Institute of Epidemiology and Hygiene, Montevideo, Uruguay; BMU ⫽ Beijing Medical University. T ⫽ ex-type culture.
2010 ISHAM, Medical Mycology, 48, 318–327
Downloaded from https://academic.oup.com/mmy/article/48/2/318/1014535 by guest on 02 September 2021
Classically, the black yeast Exophiala jeanselmei has been
reported to be involved in subcutaneous lesions of traumatic
origin, eventually causing eumycetoma [3,4]. Members of
the ascomycete order Chaetothyriales, are remarkably frequently encountered and reported as agents of disease. Many
of these species are oligotrophic [5] and are therefore found
in uncommon habitats. This property also seems to be a predisposing factor for human infection, since a large number
of species are found as etiologic agents of disease. Several
members of Chaetothyriales have been reported involved in
eumycotic mycetoma in humans and animals. Werlinger et
al. [6] and Bonifaz et al. [7] described cases of mycetoma
caused by Cladophialophora bantiana. Guillot et al. [8]
reported on a case in a dog caused by the same species.
Cladophialophora mycetomatis is a novel species recently
described by Badali et al. [9] as an agent of eumycetoma in
Mexico.
Black yeasts identified as E. jeanselmei have also been
reported from many other types of infection, such as chromoblastomycosis or mild cutaneous disease [10], disseminated infections, endocarditis and arthritis [11]. However,
recent molecular studies have shown that the species is
very heterogeneous. The original morphological varieties
have now been raised to species level [12], and additional,
morphologically nearly indistinguishable species have
been described [13]. Hence, the clinical predilection of
E. jeanselmei has to be re-evaluated on the basis of correctly identified material. With obsolete mycological procedures, identification of black yeasts remains difficult [3].
Since the original isolates no longer are available for most
cases published in older literature, their identification down
319
320
Badali et al.
2% Malt Extract Agar (MEA; Difco) and Oatmeal Agar
(OA; Difco) and incubated at 24°C for two weeks [15].
The identification of 17 strains was verified with sequence
data of the internal transcriber spacer regions (ITS) of the
rDNA. An isolate from a recent case of mycetoma was
added (CBS 122339).
Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands. If the similarity of sequences of the ITS region was
more than 99% between a studied strain and its nearest
neighbor, the strain concerned was considered to be the
same species as its nearest neighbor.
In vitro susceptibility
DNA extraction and sequencing
Alignment and phylogenetic reconstruction
Sequence data obtained in this study were adjusted using
the SeqMan of Lasergene software (DNAStar Inc.,
Madison, Wisconsin, USA). ITS sequences were aligned
manually using BioNumerics version 4.61 (Applied Maths,
Kortrijk, Belgium). The program RAxML-VI-HPC v.7.0.0
[17], as implemented on the Cipres portal v.1.10, was used
for the tree search and the bootstrap analysis (GTRMIX
model of molecular evolution and 500 bootstrap replicates).
Bootstrap values equal or greater than 70% were considered
significant [18]. Newly generated sequences were subjected
to a BLAST search of the NCBI databases, sequences with
high similarity (ⱖ98%) were downloaded from GenBank
and sequences were compared based on the alignment using
a black yeast molecular database maintained at the
MICs (minimum inhibitory concentration) and MECs (minimum effective concentration, echinocandins only) were
determined as described in the Clinical and Laboratory Standards Institute (CLSI; formerly NCCLS) document M38-A2
[19]. The eight antifungal agents evaluated: amphotericin B
(AMB, Bristol-Myers Squib, Woerden, The Netherlands);
fluconazole (FLU, Pfizer Central Research Sandwich, U.K.);
itraconazole (ITC, Janssen Research Foundation, Beerse,
Belgium); voriconazole (VOR, Pfizer); posaconazole (POS,
Schering-Plough, Kenilworth, USA); isavuconazole (ISA,
Basilea, Basel, Switzerland); caspofungin (CAS, Merck
Sharp & Dohme, Haarlem, The Netherlands) and anidulafungin (ANI, Pfizer) were provided by the manufacturers as
reagent-grade powders. As per the CLSI guidelines, stock
solutions of the drugs were prepared in the appropriate solvent [19]. The drugs were diluted in the standard RPMI1640 medium (Sigma Chemical Co.) buffered to pH 7.0
with 0.165 M morpholinepropanesulfonic acid (MOPS) buffer (Sigma) with L-glutamine without bicarbonate to yield
two times their concentrations were as follows: amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin 0.016–16 μg/ml; fluconazole 0.063–64 μg/ml;
isavuconazole 0.002–2 μg/ml and anidulafungin 0.008–8
μg/ml. Plates were stored at −70°C until they were used.
Briefly, inoculum suspensions were prepared from 7 to 14
days potato dextrose agar (PDA; Difco) cultures by adding
sterile saline solution with Tween 40 (0.05%) and slightly
scarping the surface of mature colonies with sterile cotton
swab. If large aggregates existed, they were allowed to settle for several minutes, the homogenous conidial suspensions were then transferred to sterile tubes and the
supernatants were performed spectrophotometrically at 530
nm wavelength to optical density (OD) that ranged from
0.17–0.15 (68 to 71 T%). Therefore, the final size of the
stock inoculum suspensions of the isolates tested ranged
from 0.4 ⫻ 104–3.1 ⫻ 104 CFU/ml as performed by quantitative colony count on sabouraud glucose agar (SGA;
Difco) to determine the viable number of colony forming
units per milliliter [19]. The inoculum suspensions which
consisted primarily of non-germinated conidia were diluted
1:50 in RPMI 1640 medium. Microdilultion plates were
incubated at 35°C and examined optically and spectrophotometrically at 420 nm after 72 h (if insufficient growth was
found, plates were incubated longer, until 96 h) for MICs
and MECs determinations. Paecilomyces variotii (ATCC
2010 ISHAM, Medical Mycology, 48, 318–327
Downloaded from https://academic.oup.com/mmy/article/48/2/318/1014535 by guest on 02 September 2021
Mycelia were grown on 2% MEA plates for 2 weeks at 24°C
[15] and a sterile blade was used to scrape off the mycelium
from the surface of the plate. DNA was extracted using an
Ultra Clean Microbial DNA Isolation Kit (Mobio, Carlsbad,
CA 92010, USA) according to the manufacturer’s instructions. DNA extracts were stored at −20°C until used [9].
Internal Transcribed Spacers rDNA (ITS) were amplified
using primers V9G and LS266 and sequenced with the internal primers ITS1 and ITS4 [16]. PCR reactions were performed on a Gene Amp PCR System 9700 (Applied
Biosystems, Foster City, USA) in 50 μl volumes containing
25 ng of template DNA, 5 μl reaction buffer (0.1 M TrisHCl, pH 8.0, 0.5 M KCl, 15 mM MgCl2, 0.1% gelatine, 1%
Triton X-100), 0.2 mM of each dNTP and 2.0 U Taq DNA
polymerase (ITK Diagnostics, Leiden, The Netherlands).
Amplification was performed with cycles of 5 min at 94°C
for primary denaturation, followed by 35 cycles at 94°C
(45 s), 52°C (30 s) and 72°C (90 s), with a final 7 min extension step at 72°C. Amplicons were purified using GFX PCR
DNA and gel band purification kit (GE Healthcare, Ltd.,
Buckinghamshire UK). Sequencing was performed as follows: 95°C for 1 min, followed by 30 cycles consisting of
95°C for 10 s, 50°C for 5 s and 60°C for 2 min. Reactions
were purified with Sephadex G-50 fine (GE Healthcare BioSciences AB, Uppsala, Sweden) and sequencing was done
on an ABI 3730XL automatic sequencer (Applied Biosystems, Foster City, CA, USA).
The clinical spectrum of Exophiala jeanselmei
Case report
A 43-year-old Thai man was admitted in 2004 to the Institute of Tropical Medicine, Antwerp, Belgium, due to a
complaint of a tumefaction that localized and developed on
the left leg at the dorsum of the foot affecting the fourth
and fifth toe (Fig. 1A,B). The patient did not remember any
history of trauma or puncture at the site of the lesion. First
surgical resection biopsy was performed in 2005 and initial
clinical diagnosis was that of chromoblastomycosis. Histopathologically there was no evidence of presence of
muriform cells. Subsequently, the patient underwent surgical excision of the medial mass with skin graft closure and
no antifungal drugs were prescribed. Two years later, he
was referred again to the Institute of Tropical Medicine,
presenting with a relapse of the lesion which consisted of
a deformed tumorous area, with nodules and multiple
draining sinuses. Sinuses discharged small amounts of sanguineous fluid without visible grains. The patient limped
due to discomfort at the site of infection. Radiography of
the foot was normal with no visible bone destruction or
osteomyelitis, and no significant regional lymphadenopathy was noted. Results of bacteriological (syphilis) and
parasitological (leishmaniosis) evaluations, and serological
test for human immunodeficiency virus (HIV) were all
negative. Laboratory investigations including full blood
count, blood chemistry and renal tests were within normal
limits, whereas liver functions were slightly disturbed, i.e.,
SGOT 46 (normal ⬍59), SGPT 82 (normal ⬍72), GGT
166 (normal ⬍73). Therapy with oral itraconazole at
400 mg/day for 6 months yielded good clinical response.
Fig. 1 (A,B) Clinical signs of mycetoma caused by Exophiala jeanselmei, deformed tumorous area of the foot, with nodules, draining sinuses with
discharging and ulcers. (C,D) Section of the biopsy material stained with hematoxylin and eosin (H&E) exhibiting pigmented granules; some were
sickle-shaped, and surrounded by a dense inflammatory infiltrate consisting of numerous neutrophils (H&E stain ⫻ 400).
2010 ISHAM, Medical Mycology, 48, 318–327
Downloaded from https://academic.oup.com/mmy/article/48/2/318/1014535 by guest on 02 September 2021
22319), Candida parapsilosis (ATCC 22019) and Candida
krusei (ATCC 6258) were used for quality control. The
MICs endpoints for amphotericin B, itraconazole, voriconazole, posaconazole and isavuconazole were determined
with the aid of a reading mirror as the lowest concentration
of the drug that prevented any recognizable growth (100%
inhibition) and for fluconazole as a prominent reduction of
growth, i.e., ⱖ50% inhibition compared to drug-free growth
control. The MEC of the echinocandins (caspofungin and
anidulafungin) was defined microscopically as the lowest
concentration of the drug that led to the growth of small,
rounded, compact hyphal forms as compared with the long,
unbranched hyphal clusters that were seen in the growth
control [19].
321
322
Badali et al.
The slight liver tests abnormalities were considered no
contraindication for itraconazole treatment, but the patient
was requested to avoid alcoholic beverages. Additional
local heat therapy (hot footbath, local heated dry pillow,
heat bag and/or infrared lamp) was suggested, but it
remained unclear how far this was implemented, since verbal communication was rather difficult. On January 2008,
there was a clear improvement of the wound, but no complete healing. Liver tests had normalized since he stopped
alcoholic drinking. Afterwards, the patient did not return
for follow up.
The entire biopsied tissue was used for mycological and
histopathological investigations. Direct examination with
KOH (10%) revealed black granules and hyphal elements
but were not obviously clear. Microscopic examination of
biopsy sections stained with hematoxylin and eosin (H&E)
revealed pigmented granules, some sickle-shaped, and surrounded by a dense inflammatory infiltrate consisting of
numerous neutrophils and to the periphery chronic inflammation with fibrosis (Fig. 1C,D). The histopathological
observations led to the diagnosis of a eumycotic mycetoma
caused by an Exophiala species.
Clinical specimens were cultured on Sabouraud glucose
agar (SGA: Difco) and SGA supplemented with chloramphenicol (0.5 μg/ml) and incubated at 27–30°C for 7 days.
Growth of dematiaceous fungi was observed and these were
morphologically classified as Exophiala species. Stock cultures were maintained on slants of 2% MEA and OA at 24°C
[15], and a voucher strain was deposited in the CBS culture
collection as CBS 122339. Microscopic studies using the
Results
Seventeen strains from different geographical locations
maintained as Exophiala jeanselmei in the CBS culture
collection were sequenced using the ITS region (542 characters) and compared with alignable members of genus
Exophiala. The ex-type strains of E. jeanselmei (AY156963),
E. spinifera (AY156976), E. exophialae (AY156973),
E. dermatitidis (FJ974060), E. oligosperma (AY163551),
E. xenobiotica (DQ182587), E. bergeri (EF551462) and
E. lecanii-corni (FJ974061) were used. The species
Fig. 2 (A) Culture on Malt extract agar (MEA, Difco) produced dark, moist, olivaceous-black yeast-like colony at room temperature. (B,C) Conidia
clustered at the apices of the tapered annellides and long, thick-walled, septate conidiophores. Scale bar ⫽ 10 μm.
2010 ISHAM, Medical Mycology, 48, 318–327
Downloaded from https://academic.oup.com/mmy/article/48/2/318/1014535 by guest on 02 September 2021
Mycological identification
slide culture techniques with PDA or OA were conducted.
These media were selected because they readily induce sporulation and suppress growth of aerial hyphae [3]. After two
weeks, slides were prepared from these cultures in lactic
acid or lactophenol cotton blue and light micrographs
were taken using Nikon Eclipse 80i microscope with a
Nikon digital sight DS-Fi1 camera. Colonies were moderately expanding and initially moist (yeast-like), forming
velvety, olivaceous-green aerial hyphae; colony reverse
was olivaceous-black (Fig. 2A). Numerous sub-spherical to
ellipsoidal budding cells were present in young cultures,
giving rise to short torulose hyphae that gradually changed
into un-swollen hyphae. Conidia were often cohering in
long chains and converted into hyphae. Conidiogenous cells
were intercalary or lateral, then rocket-shaped, brown,
with inconspicuous, slightly tapering annellated zones,
producing smooth, narrow, thin-walled, broadly ellipsoidal
conidia 2.6–5.9 ⫻ 1.2–2.5 μm (Fig. 2B,C). Cardinal
growth temperatures of strain CBS 122339 were growth
between 9–37°C, optimum at 27°C, no growth was observed
at 40°C.
The clinical spectrum of Exophiala jeanselmei
Fig. 3 Consensus tree of ITS rDNA obtained from
a ML analysis using RAxML. Bootstrap support
values were estimated based on 500 replicates, and
are shown above the branches. The Exophiala
dermatitidis Clade was taken as outgroup.
2010 ISHAM, Medical Mycology, 48, 318–327
infections were considered to belong to E. oligosperma and
E. xenobiotica [24].
Table 2 summarizes the results of in vitro antifungal
susceptibility testing of eight antifungal drugs against
E. jeanselmei (n ⫽ 9) and E. oligosperma (n ⫽ 5) employing the methods described in the CLSI guideline
(M38-A2). The MIC90 was not determined due to insufficient numbers of isolates. Amphotericin B MICs for most
non-dermatophyte opportunistic filamentous fungi isolates
are clustered between 0.5–2 μg/ml. However, there is very
little data available regarding the correlation between
MICs and outcome of treatments with AmB for filamentous fungi. Results have shown that amphotericin B
Downloaded from https://academic.oup.com/mmy/article/48/2/318/1014535 by guest on 02 September 2021
E. jeanselmei was unambiguously distinguished in a
robust branch with ⬎98% bootstrap support (Fig. 3). Nine
out of 17 strains showed 98% identity with the E. jeanselmei
ex-type strain (CBS 507.90) which had originally been
isolated from a true mycetoma-like infection. Five
strains were re-identified as E. oligosperma, and one strain
each was confirmed as E. bergeri (CBS 102241),
E. xenobiotica (CBS 527.76) and Capronia pilosella (CBS
663.76) (Table 1). Strains confirmed to be E. jeanselmei
all originated from subcutaneous infections in human
patients [current case,10,13,20-23], whereas strains which
originated from environmental samples like soil, wood
and plant or from clinical relevant eye or disseminated
323
324
Badali et al.
Table 2 In vitro susceptibility of Exophiala jeanselmei and Exophiala
oligosperma for eight antifungal drugs expressed in μg/ml.
Source (no. of strains) and drugs
MIC50
0.25–2
8–32
0.031–0.25
0.25–2
0.016–0.063
0.25– ⬎ 2
2–8
0.063–4
1
16
0.125
1
0.031
2
4
0.5
1–2
16–32
0.031–0.25
1–4
0.016–0.125
0.5–2
0.25–4
0.016–2
1
32
0.063
1
0.031
1
4
0.5
Note. MIC90 not determined due to insufficient numbers of isolate
tested.
MICs ranged from 0.25–2.0 and 1–2 μg/ml for E. jeanselmei
and E. oligosperma, respectively. Itraconazole and posaconazole showed potent activity against all E. jeanselmei
and E. oligosperma isolates. Interestingly in terms of
MIC50 (0.031 μg/ml) posaconazole was more active against
E. jeanselmei than itraconazole (MIC50 0.125). Filamentous fungi are usually not susceptible to fluconazole
and most MICs are ⬎64 μg/ml for these isolates. In our
study, we found that fluconazole had the widest range and
the highest MICs against E. jeanselmei and E. oligosperma,
ranging between 8–32 and 16–32 μg/ml, respectively.
Voriconazole and isavuconazole had highest MICs
with complete inhibition end points with MIC50 (1 μg/ml
and 2 μg/ml) against E. jeanselmei and MIC50 (both 1 μg/ml)
against E. oligosperma. Posaconazole demonstrated the
lowest MIC50 (0.031 μg/ml) of all azoles. Concerning the
echinocandin drugs caspofungin and anidulafungin, both
exhibited low in vitro activity against E. jeanselmei and E.
oligosperma. Exophiala jeanselmei showed higher MEC50
(4 μg/ml) with caspofungin than to anidulafungin
(MEC50⫽0.5 μg/ml). Overall, in terms of MEC50 caspofungin
had no activity against E. jeanselmei and E. oligosperma.
There was no statistically significant difference when comparing the susceptibilities of E. jeanselmei and E. oligosperma
isolates for all antifungal drugs (P⬍0.05).
Discussion
In our previous studies, phylogenetic analysis of nucSSU,
nucLSU and RPB1 genes have shown that the ex-type
strain of E. jeanselmei (CBS 507.96) is a member of the
2010 ISHAM, Medical Mycology, 48, 318–327
Downloaded from https://academic.oup.com/mmy/article/48/2/318/1014535 by guest on 02 September 2021
Exophiala jeanselmei (9)
Amphotericin B
Fluconazole
Itraconazole
Voriconazole
Posaconazole
Isavuconazole
Caspofungin
Anidulafungin
Exophiala oligosperma (5)
Amphotericin B
Fluconazole
Itraconazole
Voriconazole
Posaconazole
Isavuconazole
Caspofungin
Anidulafungin
MIC range
order Chaetothyriales, within the family Herpotrichiellaceae [9,25]. Identification of this and related fungi with
standard mycological procedures is difficult because of
their high numbers of budding cells and poorly differentiated conidial structures. Nishimura et al. [26] studied the
conidiogenesis of E. dermatitidis, E. jeanselmei, and
E. spinifera and reported that the conidial ontogenesis of
these three species is annellidic and may sometimes be
difficult to differentiate. Masuda et al. [27] and Dixon
et al. [28] showed that the morphological variants of
E. jeanselmei distinguished earlier by de Hoog [29] are
quite distinct on the molecular level and subsequently segregated into a number of individual species. Masuda et al.
used DNA-DNA hybridization to classify E. jeanselmei
into six groups. They suggested that DNA similarities
between one group and another seem too low for these
groups to comprise a single species [27]. Kawasaki et al.
classified strains of E. jeanselmei into 18 types based on
mitochondrial restriction profiles and believed that the
organism constitutes a complex [30]. Wang et al. [31] used
the DNA and amino acid types of the mitochondrial
cytochrome b. They proposed that on the basis of mtDNA
RFLP typing and similarities of nucleotide and amino
acid sequences, that some E. jeanselmei strains should
be re-identified. Moreover, Haase et al. suggested
E. jeanselmei var. lecanii-cornii should be a distinct species, Exophiala lecanii-corni, based on investigation of
ribosomal DNA [32].
In the present study, considerable sequence differences
were found in nine out of 17 strains in the CBS culture
collection. The isolate from the present case report exhibited ⱖ98% ITS similarity to the ex-type strain of
E. jeanselmei (CBS 507.90) and formed a single cluster of
E. jeanselmei and consequently should be regarded as
identical to this species. The intraspecific variability within
two strains ITS1 region was 2 bp (in the nucleotide position
of 82 and 107) and 4 bp in ITS2 region (in the nucleotide
position of 492, 519, 528 and 531), positions of ITS1 and
2 are counted after ATCATT. The ex-type strain originated
from a case of mycetoma in a patient in France who was
an immigrant from Martinique [20]. Strain CBS 116.86
represents the etiologic agent of chromoblastomycosis-like
infection [10] with muriform cells in tissue. However, the
clinical manifestation and the tissue form are different
from that of the grains described by Langeron [20]. CBS
677.76 originated from a black-grain mycetoma in a patient
from Pakistan [21] and formed grains in vivo that were
morphologically identical to those formed by the ex-type
strain that also originated from mycetoma. Sequence data
of CBS 677.76 proved it to be close to E. jeanselmei. CBS
148.97 caused phaeohyphomycotic cysts in a 59-year-old
Japanese male with enlarging nodules on his finger
and forearm associated with wooden splinters [22]. It was
The clinical spectrum of Exophiala jeanselmei
2010 ISHAM, Medical Mycology, 48, 318–327
voriconazole against molecularly confirmed Exophiala
species. In the first, 188 clinical strains were analyzed and
most appeared to be susceptible to the four widely used
antifungal agents, except Exophiala attenuata which was
resistant to amphotericin B. MIC50s of all E. jeanselmei
isolates relative to amphotericin B, itraconazole, voriconazole and posaconazole were 0.5, 0.03, 0.125 and ⱕ0.015
μg/ml, respectively, whereas the MIC50s for E. oligosperma
were 0.25, 0.06, 0.25, and 0.03 μg/ml respectively [35].
Fothergill et al. [36] studied the in vitro susceptibility
to amphotericin B, itraconazole, posaconazole and
voriconazole of 160 Exophiala strains including
E. jeanselmei (n⫽8, originating from subcutaneous and
deep infections) and E. oligosperma (n⫽40, from
cutaneous, subcutaneous and deep infection). Concerning
E. jeanselmei, the MIC50s were determined for amphotericin B (0.5 μg/ml), itraconazole (0.03 μg/ml), posaconazole
(⬍0.015 μg/ml) and voriconazole (0.125 μg/ml) but
posaconazole was more active than others antifungals
[36]. Similar results were found in our series, posaconazole showed high activity against E. jeanselmei and
E. oligosperma in terms of MIC50. In vitro testing of isavuconazole and voriconazole exhibited broad-spectrum
activity against the majority of the opportunistic and
pathogenic fungi [37]. In the present study, low in vitro
activities isavuconazole (MIC50 2 μg/ml) and caspofungin
(MIC50 4 μg/ml) were found with E. jeanselmei suggesting
that these drugs might not be the optimal choice for
treatment. In contrast, posaconazole demonstrated potent
in vitro activity (MIC50 0.031 μg/ml) against E. jeanselmei
that cause mycetoma. Itraconazole has been used clinically
in cases of mycetoma due to E. jeanselmei, with successful
outcome [38]. Voriconazole has only been employed
in some cases of cutaneous infections [39]. Isavuconazole
until now has not been used clinically for Exophiala
infections, but itraconazole was the only clinically active
antifungal drug in the treatment of mycetoma due to
E. jeanselmei. Infections by Exophiala species may require
a combination of surgical and medical treatment. Although
amphotericin B and itraconazole, with or without
additional flucytosine, are currently regarded to be efficacious against cutaneous and subcutaneous lesions, the newer
triazole agents, itraconazole and posaconazole, expand the
therapeutic options for these mycoses. In conclusion, posaconazole and itraconazole demonstrated the highest in vitro
antifungal activity against E. jeanselmei and E. oligosperma
that had high MICs for caspofungin. Therefore posaconazole and itraconazole seem to be the most active drugs for
treating Exophiala infections. We did not investigate the
relation between MIC and clinical response to treatment;
their clinical effectiveness in the treatment of Exophiala
infections remains to be determined.
Downloaded from https://academic.oup.com/mmy/article/48/2/318/1014535 by guest on 02 September 2021
identified as E. jeanselmei by morphological and molecular analysis. In contrast, the remaining strains (CBS 119095,
CBS 109635, CBS 528.76 and CBS 664.76) from unpublished cases were maintained as originating from cutaneous infections (arm, hand or foot). Environmental strains
formerly identified as E. jeanselmei were considered to be
distinct from E. jeanselmei s. str. They were within 1%
differences with ex-type strains of E. oligosperma (CBS
725.88), E. xenobiotica (CBS 118157) and E. bergeri (CBS
353.52) (Fig. 3). Although E. oligosperma is phenotypically similar to E. jeanselmei and has mostly been confused with that taxon, genetically the species are clearly
distinct.
In our case report on CBS 122339, granules, the hallmark of mycetoma, were seen histopathologically in tissue
(Fig. 1C,D). Parts of the grains were reniform, and clinical
features of mycetoma, such as tumefaction, abscess formation, and fistulae were observed.
In summary, nine strains confirmed as E. jeanselmei
originated from mycetoma or subcutaneous phaeohyphomycosis, as well as in one instance from chromoblastomycosis according to histopathological examination. Strains
with identity (100%) or near-identity (approximately 99%)
with the ex-type strain of E. jeanselmei appeared to be very
consistent in clinical behavior. The case of chromoblastomycosis is remarkable. The switch between grain and
muriform cell as a response to host factors needs to be
studied.
Over the past two decades, more serious black yeast
infections have been recognized. Different antifungal
agents have been used in the treatment of mycetoma, such
as amphotericin B, fluorocytosine, itraconazole, fluconazole, and voriconazole [33]. In the past, amphotericin B
was the most potent antifungal drug for severe invasive
fungal infections, but its use is associated with severe side
effects, particularly nephrotoxicity and low efficacy and its
use has been replaced by newer azoles and echinocandins.
Unfortunately, little data are available on the in vitro antifungal susceptibility of conventional and new antifungal
agents against confirmed strains of E. jeanselmei. In a
comparative overview of in vitro activities of posaconazole, itraconazole, voriconazole, and amphotericin B
against over 19,000 clinically yeasts and moulds, just 14
Exophiala species were included, without molecular identification [34]. Data have shown that posaconazole has
good activity against agents that cause chromoblastomycosis, mycetoma, and phaeohyphomycosis, including Exophiala species and posaconazole was generally more active
than itraconazole and amphotericin B against these organisms [34,35].
Two recent studies reported in vitro antifungal data
on amphotericin B, itraconazole, posaconazole and
325
326
Badali et al.
Acknowledgements
This study and the work of Hamid Badali were funded by
a grant (No. 13081) from the Ministry of Health and Medical Education of Islamic Republic of Iran and the School
of Medicine, Mazandaran University of Medical Sciences,
Sari, Iran. In addition, a part of this study was supported
by a grant from Basilea Pharmaceutica, Basel, Switzerland.
We thank I. Curfs-Breuker for help in building up part of
the antifungal susceptibility test.
References
1 McGinnis MR. Mycetoma. Dermatol Clin 1996; 14: 97–104.
2 Hay RJ. Agents of eumycotic mycetomas. In: Ajello L, Hay RJ (eds).
Topley and Wilson’s Microbiology and Microbial Infections, vol. 4.
Mycology. London: Arnold, 2000: 487–496.
3 De Hoog GS, Guarro J, Gene J, Figueras MJ. Atlas of Clinical Fungi, 2nd
ed. Utrecht/Reus: Centraalbureau voor Schimmelcul-tures/Universitat
Rovira i Virgili, 2000.
4 Bittencourt AL, Londero AT. Tropical mycotic diseases. In: Doerr
BW, Uehlinger E (eds). Tropical Pathology, 2nd edn. Vol. 8. Berlin:
Springer Verlag, 1995: 707–798.
5 Satow MM, Attili-Angelis D, De Hoog GS, et al. Selective factors involved in oil flotation isolation of black yeasts from the environment.
Stud Mycol 2008; 61: 157–163.
6 Werlinger KD, Yen Moore A. Eumycotic mycetoma caused by Cladophialophora bantiana in a patient with systemic lupus erythematous.
J Am Acad Dermatology 2005; 52: 114–117.
7 Bonifaz A, De Hoog GS, McGinnis MR, et al. Eumycetoma caused
by Cladophialophora bantiana successfully treated with itraconazole.
Med Mycol 2009; 47: 111–114.
8 Guillot J, Garcia-Hermoso D, Degorce F, et al. Eumycetoma caused
by Cladophialophora bantiana in a dog. J Clin Microbiol 2004; 42:
4901–4903.
9 Badali H, Gueidan C, Najafzadeh MJ, et al. Biodiversity of the genus
Cladophialophora. Stud Mycol 2008; 61: 175–191.
10 Naka W, Harada T, Nishikawa T., Fukushiro R. A case of chromoblastomycosis with special reference to the mycology of the isolated
Exophiala jeanselmei. Mykosen 1986; 29: 445–452.
11 Nucci M, Akiti T, Barreiros G, et al. Nosocomial fungemia due to
Exophiala jeanselmei var. jeanselmei and a Rhinocladiella species:
newly described causes of bloodstream infection. J Clin Microbiol
2001; 39: 514–518.
12 De Hoog GS, Takeo K, Yoshida S, et al. Pleoanamorphic life cycle of
Exophiala (Wangiella) dermatitidis. Antonie van Leeuwenhoek 1994;
65:143–153.
13 De Hoog GS, Vicente V, Caligiorne RB, et al. Species diversity and
polymorphism in the Exophiala spinifera clade containing opportunistic black yeast-like fungi. J Clin Microbiol 2003; 41: 4767–4778.
14 Desnos-Ollivier M, Bretagne S, Dromer F, et al. Molecular identification of black-grain mycetoma agents. J Clin Microbiol 2006; 44:
3517–3523.
15 Gams W, Verkley GJM, Crous PW. CBS Course of Mycology,
5th ed. Utrecht: Centraalbureau voor Schimmelcultures, 2007.
2010 ISHAM, Medical Mycology, 48, 318–327
Downloaded from https://academic.oup.com/mmy/article/48/2/318/1014535 by guest on 02 September 2021
Declaration of interest: The authors report no conflicts of
interest. The authors alone are responsible for the content
and writing of the paper.
16 White TJ, Bruns T, Lee S, Taylor J. Amplification and direct
sequencing of fungal ribosomal RNA genes for phylogenetics. In:
InnisMA, Gelfand DA, Sninsky JJ, White TJ (eds). PCR Protocols:
A Guide to Methods and Applications. SanDiego: Academic Press,
1990; 315–322.
17 Stamatakis A, Hoover P, Rougemont J. A rapid bootstrap
algorithm for the RAxML Web-Servers. System Biol 2008; 57:
758 – 771 .
18 Hillis DM, Bull JJ. An empirical test of bootstrapping as a method
for assessing confidence in phylogenetic analysis. System Biol 1993;
42: 182–192.
19 Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous
fungi. Approved Standard M38-A2; 2nd edn: CLSI, Wayne, PA, USA,
2008.
20 Langeron M. Mycétome à Torula jeanselmei Langeron, 1928. Nouveau type de mycétome à grains noirs. Ann Parasitol Hum Comp
1928; 6: 385–403.
21 Murray IG, Dunkerley GE, Hughes KEA. A case of Madura foot
caused by Phialophora jeanselmei. Sabouraudia 1963; 3:175–177.
22 Kawachi Y, Tateishi T, Shojima K, et al. Subcutaneous phaeomycotic
cyst of the finger cased by E. jeanselmei: association with a wood
splinter. Cutis 1995; 56: 41–43.
23 Yamada Y, sugihara K, Van Eijk GW, et al. Coenzyme Q system in
ascomycetous black yeasts. Antonie van Leeuwenhoek 1989; 56:
349–356.
24 Bossler AD, Richter SS, Chavez AJ, et al. Exophiala oligosperma
causing olecranon bursitis. J Clin Microbiol 2003; 41: 4779–4782.
25 Badali H, Carvalho VO, Vicente V, et al. Cladophialophora saturnica
sp. nov., a new opportunistic species of Chaetothyriales revealed using molecular data. Med Mycol 2009; 47: 51–62.
26 Nishimura K, Miyaji M. Studies on the phylogenesis of pathogenic
‘black yeasts. Mycopathologia 1983; 81: 135–144.
27 Masuda M, Naka W, Tajima S, et al. Deoxyribonucleic acid hybridization studies of Exophiala dermatitidis and Exophiala jeanselmei.
Microbiol Immunol 1989; 33: 631–639.
28 Dixon DM, Polak-Wyss A. The medically important dematiaceous
fungi and their identification. Mycoses 1991; 34:1–18.
29 De Hoog GS. Rhinocladiella and allied genera. Stud Mycol 1977; 15:
1–144.
30 Kawasaki M, Ishizaki H, Matsumoto T, et al. Mitochondrial DNA
analysis of Exophiala jeanselmei var. lecanii-corni and Exophiala
castellanii. Mycopathologia 1999; 146: 75–77.
31 Wang L, Yokoyama K, Miyaji M, Nishimura K. Identification, classification, and phylogeny of the pathogenic Species Exophiala
jeanselmei and related species by mitochondrial cytochrome b gene
analysis. J Clin Microbiol 2001; 39: 4462–4467.
32 Haase G, Sonntag L, Melzer-Krick B, de Hoog GS. Phylogenetic inference by SSU-gene analysis of members of the Herpotrichiellaceae
with special reference to human pathogenic species. Stud Mycol 1999;
43: 80–97.
33 Ameen M, Arenas R. Emerging therapeutic regimes for the
management of mycetomas. Expert Opin Pharmacother 2008; 9:
2077–2085.
34 Sabatelli F, Patel R, Mann PA, et al. In vitro activities of posaconazole,
fluconazole, itraconazole, voriconazole, and amphotericin B against a
large collection of clinically important molds and yeasts. Antimicrob
Agents Chemother 2006; 50: 2009–2015.
35 Zeng JS, Sutton DA, Fothergill AW, et al. Spectrum of clinically
relevant Exophiala species in the U.S.A. J Clin Microbiol 2007; 45:
3713–3720.
36 Fothergill AW, Rinaldi MG, Sutton DA. Antifungal susceptibility testing of Exophiala spp: a head to head comparion of amphotericin B,
The clinical spectrum of Exophiala jeanselmei
itraconazole, posaconazole and voriconazole. Med Mycol 2009; 47:
41–43.
37 Guinea J, Peláez T, Recio S. In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates
of Zygomycetes, Candida, Aspergillus, Fusarium, and Scedosporium
species. Antimicrob Agents Chemother 2008; 52: 1396–1400.
327
38 Jaffar A, Tawfiq AL, Amr SS, Madura leg due to Exophiala jeanselmei
successfully treated with surgery and itraconazole therapy. Med
Mycol 2009; 1-5 iFirst. DOI: 10.1080/13693780802669194.
39 Loulergue P, Hot A, Dannaoui E, et al. Successful treatment of black
grain mycetoma with voriconazole. Am J Trop Med Hyge 2006; 75:
1106–1107.
This paper was first published online on Early Online on 01 February
2010.
Downloaded from https://academic.oup.com/mmy/article/48/2/318/1014535 by guest on 02 September 2021
2010 ISHAM, Medical Mycology, 48, 318–327